Drug Type CAR-NK |
Synonyms- |
Mechanism EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists), EphA2 antagonists(Ephrin type-A receptor 2 antagonists), HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Discovery | CN | 25 Nov 2022 |